Hélène Goulaouic
Sanofi (France)(FR)
Publications by Year
Research Areas
Liver physiology and pathology, HIV Research and Treatment, HIV/AIDS drug development and treatment, Asthma and respiratory diseases, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy(2014)481 cited
- → Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma(2021)386 cited
- → The Bloom's Syndrome Gene Product Interacts with Topoisomerase III(2000)316 cited
- → Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial(2021)192 cited
- → Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein(1996)96 cited
- → Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors(2014)90 cited
- → Purification and characterization of human DNA topoisomerase IIIalpha(1999)80 cited
- → Triplex-mediated inhibition of HIV DNA integration in vitro.(1994)55 cited
- → Triple Helix Formation with Short Oligonucleotide-Intercalator Conjugates Matching the HIV-1 U3 LTR End Sequence(1994)51 cited
- → Inhibitory Effect of the Polyanionic Drug Suramin on the in Vitro HIV DNA Integration Reaction(1993)47 cited